Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Gurnet Point, Novo Holdings Buy Out Paratek

Jun 12 2023

• By Joseph Haas

Deal Watch 2021 — • Source: Shutterstock

Related Content

Stealth Elamipretide NDA Tests Frontiers Of US FDA’s Flexibility In Rare Diseases

Sep 03 2021

Rhythm Wins Reimbursement For Obesity Drug Imcivree In France & England

Aug 02 2022

UAE’s Bioventure Is Looking For Partners To Expand

May 30 2023

What’s Next? Five Things To Look Out For In June

Jun 01 2023

Samsung Biologics Strikes $400m+ Biosimilars Supply Deal With Pfizer

Jun 09 2023

Neuraxpharm Brings In Greek Olanzapine Brand

Jun 07 2023

Generics Bulletin Explains: Sandoz’s Spinoff From Novartis

Jun 06 2023

Synaffix Aims For Top ADC Tech Provider Spot After Inking MacroGenics Deal

Feb 08 2022

After US Woes, Akebia Celebrates EU Nod For Vafseo

Feb 27 2023

Asia Deal Watch: Astellas Begins 2023 Signing Rare Disease Tie-Ups With Selecta, Twist

Jan 13 2023

Novartis Aims To Fly High In Kidney Disease With Chinook Buy

Jun 12 2023

Next-Gen Gene Therapy Firm Kate Therapeutics Starts Out With Big Pharma Partner

Jun 08 2023

AstraZeneca To Partner With Quell In Buzzing Treg Field

Jun 09 2023

BIO Notebook: Sanofi Hunts For Later-Stage Assets; Orphan Drug Sponsors Hunt For Legislative Fixes

Jun 07 2023

BIO Notebook: GSK’s Walmsley On M&A, Merck On How Falling Valuations Are Affecting Deals

Jun 06 2023

Egetis Ends Takeover Talks To Focus On Emcitate

May 26 2023

Podcast: What Does The Pfizer/Seagen Merger Mean For M&A In 2023?

May 24 2023

ElevateBio Raises $401m To Fund Its Own And Partners’ Future Cell And Gene Therapy Needs

May 24 2023

Deal Watch: Seattle Genetics' Controversial Collaboration With Immunomedics Topples

May 05 2017

Pyxis’s $152m Series B Will Push Trio Of ADCs Toward Clinic

Mar 30 2021

Alvotech Makes Multiple Moves As It Allies With Advanz For Five European Biosimilars

May 24 2023

Novo Nordisk In Negotiations To Acquire Medical Device Maker Biocorp For About $165M (€154M)

Jun 05 2023

Deal Watch: Roche Partners With Dyno On AAV-Delivered Gene Therapies

Oct 14 2020

Theragnostics Ltd: Developing New Radiotherapies Targeted To PARP

Nov 01 2019

Related Companies

Terran Biosciences, Inc.

Pierre Fabre

Johnson & Johnson

Levolta Pharmaceuticals

Tabuk Pharmaceutical Manufacturing Co.

Bayer AG

Cedilla Therapeutics

Genfit SA

Seal Rock Therapeutics, Inc.

Adcendo ApS

Duality Biologics

Oxford BioTherapeutics

Akebia Therapeutics, Inc.

Medice Arzneimittel Putter GmbH & Co KG

Rhythm Pharmaceuticals, Inc.

Genpharm Services

Lonza Group AG

Synaffix B.V.

Pyxis Oncology

Apexigen, Inc.

CohBar, Inc.

TuHURA Biosciences, Inc.

Pfizer Inc.

Ariceum Therapeutics GmbH

Theragnostics Ltd.

Stealth BioTherapeutics Inc.

Additional Topics

Business Strategies Deals M & A Commercial Deal Watch BioPharmaceutical

More from Deal Watch

More from Deals

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.